Adeno-Associated Virus 2 and Human Adenovirus F41 in Wastewater during Outbreak of Severe Acute Hepatitis in Children, Ireland.
AAV2
HAdV-F41
Ireland
adeno-associated virus 2
adenovirus
enteric infections
hepatitis
human adenovirus F41
pediatric hepatitis
viruses
wastewater-based epidemiology
Journal
Emerging infectious diseases
ISSN: 1080-6059
Titre abrégé: Emerg Infect Dis
Pays: United States
ID NLM: 9508155
Informations de publication
Date de publication:
04 2023
04 2023
Historique:
entrez:
23
3
2023
pubmed:
24
3
2023
medline:
28
3
2023
Statut:
ppublish
Résumé
During April-July 2022, outbreaks of severe acute hepatitis of unknown etiology (SAHUE) were reported in 35 countries. Five percent of cases required liver transplantation, and 22 patients died. Viral metagenomic studies of clinical samples from SAHUE cases showed a correlation with human adenovirus F type 41 (HAdV-F41) and adeno-associated virus type 2 (AAV2). To explore the association between those DNA viruses and SAHUE in children in Ireland, we quantified HAdV-F41 and AAV2 in samples collected from a wastewater treatment plant serving 40% of Ireland's population. We noted a high correlation between HAdV-F41 and AAV2 circulation in the community and SAHUE clinical cases. Next-generation sequencing of the adenovirus hexon in wastewater demonstrated HAdV-F41 was the predominant HAdV type circulating. Our environmental analysis showed increased HAdV-F41 and AAV2 prevalence in the community during the SAHUE outbreak. Our findings highlight how wastewater sampling could aid in surveillance for respiratory adenovirus species.
Identifiants
pubmed: 36957994
doi: 10.3201/eid2904.221878
pmc: PMC10045691
doi:
Substances chimiques
Wastewater
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
751-760Références
HLA. 2021 Jan;97(1):15-29
pubmed: 33128327
J Hepatol. 2022 Jul;77(1):237-242
pubmed: 35533802
Mol Ther. 2015 Nov;23(11):1673-1675
pubmed: 26606658
Bioinformatics. 2014 May 1;30(9):1312-3
pubmed: 24451623
J Med Virol. 2017 Jul;89(7):1192-1200
pubmed: 27943297
Nat Biotechnol. 2022 Dec;40(12):1814-1822
pubmed: 35851376
Nat Methods. 2021 Apr;18(4):366-368
pubmed: 33828273
Gene Ther. 2012 Mar;19(3):288-94
pubmed: 21697954
Hum Gene Ther. 2017 Apr;28(4):323-327
pubmed: 27832705
N Engl J Med. 2022 Aug 18;387(7):620-630
pubmed: 35830653
J Virol Methods. 1996 May;59(1-2):73-82
pubmed: 8793832
Sci Total Environ. 2020 Sep 20;736:139631
pubmed: 32474280
Lancet Public Health. 2020 May;5(5):e279-e288
pubmed: 32311320
Sci Total Environ. 2022 Jan 20;805:149877
pubmed: 34818780
J Clin Virol. 2018 Dec;109:35-40
pubmed: 30399502
Arch Virol. 2006 Aug;151(8):1587-602
pubmed: 16502282
Virus Evol. 2022 Oct 20;8(2):veac098
pubmed: 36381230
Sci Total Environ. 2022 Sep 10;838(Pt 2):155828
pubmed: 35588817
Sci Adv. 2021 Jan 8;7(2):
pubmed: 33523995
Virol J. 2005 Feb 10;2:6
pubmed: 15705203
BMC Infect Dis. 2019 Jan 14;19(1):53
pubmed: 30642268
Emerg Infect Dis. 2020 Aug;26(8):
pubmed: 32396505
Bioinformatics. 2016 Nov 1;32(21):3246-3251
pubmed: 27378296
Sci Total Environ. 2023 Jan 20;857(Pt 2):159579
pubmed: 36270375
Nucleic Acids Res. 2012 Dec;40(22):11189-201
pubmed: 23066108
Appl Environ Microbiol. 2014 Nov;80(21):6771-81
pubmed: 25172863
Sci Rep. 2022 Sep 22;12(1):15777
pubmed: 36138059
J Korean Med Sci. 2022 May 30;37(21):e172
pubmed: 35638198
Semin Respir Crit Care Med. 2016 Aug;37(4):586-602
pubmed: 27486739
Bioinformatics. 2018 Sep 15;34(18):3094-3100
pubmed: 29750242
Front Med. 2022 Dec;16(6):984-990
pubmed: 36152125
Microb Biotechnol. 2017 Nov;10(6):1775-1780
pubmed: 28925595